England has initiated a screening program for over 200 rare genetic conditions in newborns to enhance diagnosis and care for up to 100,000 babies. The Generation Study involves blood samples from the umbilical cord for whole genome sequencing, aiming to inform parents within 28 days about potential treatable genetic disorders. While the initiative promises earlier diagnosis and treatment, concerns about false positives and the need for careful follow-up have been raised. Similar efforts are being made in the EU to address disparities in rare disease screening. Teljes cikk (Euronews.com)